Research Article
Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients
Table 4
Characteristics of the deceased patients.
| | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
| Age | 59 | 49 | 68 | 72 | Sex | Male | Female | Female | Female | AIH presentation | Fulminant | Fulminant | Fulminant | Fulminant | Chronic hepatitis | Yes | No | No | Yes | Necrosis | No | No | Severe | No | Fibrosis | F4 | F4 | F1 | F1 | Treatment with steroids | Yes | No | No | Yes | Liver transplantation | Yes | Yes | Yes | No | Total bilirubin—(mg/dL) | 30.3 | 28.8 | 7.2 | 17.5 | AST/ALT—(U/L) | 378/433 | 863/602 | 9547/4276 | 1847/1012 | Immunoglobulin G—(mg/dL) | 1900 | 1070 | 1530 | 2450 | Prothrombin—(%) | 26 | 40 | 48 | 44 | MELD | 30 | 25 | 19 | 23 | ANA | 1/640 | 1/80 | 1/80 | 1/640 | SMA | 1/640 | 1/320 | (—) | 1/320 | Cause of death | Septic shock | Septic shock | Septic shock | Septic shock |
|
|
AST: aspartate aminotransferase; ALT: alanine aminotransferase; ANA: antinuclear antibody; SMA: smooth muscle antibody; MELD: model of end-stage liver disease.
|